Young boys who ate a greater proportion of ultraprocessed foods were more likely to develop overweight or obesity by age 5 years, according to findings published in JAMA Network Open.“Ultraprocessed ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Researchers at the University of Toronto are sounding the alarm about the high consumption of ultra-processed foods among preschool-aged children in Canada and its association with obesity development ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...

(HealthDay News) — For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes ...